Eversept Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Eversept Partners’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-98,501	Closed	-$5.17M	–	73
2020 Q3	$5.17M	Sell	98,501 -25,837	-21%	-$1.07M	1.15%	24
2020 Q2	$4.14M	Sell	124,338 -22,212	-15%	-$707K	0.57%	33
2020 Q1	$3.99M	Buy	+146,550	New	+$4.08M	0.99%	23

Eversept Partners's MNTA Position: Q4 2020 in Review

Eversept Partners sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 98,501 shares — an estimated $5.17M sold.

Eversept Partners first reported a position in MNTA in Q1 2020 and held it in 3 quarters. The position peaked at $5.17M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Eversept Partners reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Eversept Partners sold 98,501 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $5.17M.
Eversept Partners first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2020 and held it in 3 quarters.
Eversept Partners's Momenta Pharmaceuticals, Inc. position peaked at $5.17M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Eversept Partners's 13F filing for Q4 2020, filed 16 Feb 2021.